Fundely
3137
Axel Mark
3624
Twenty-four seven
7074
Visumo
303A
Nomura Micro Science
6254
(FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | (FY)Dec 31, 2018 | (FY)Dec 31, 2017 | (FY)Dec 31, 2016 | (FY)Dec 31, 2015 | (FY)Dec 31, 2014 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | -5.95%9.35B | 24.37%9.95B | 21.39%8B | -13.52%6.59B | 22.48%7.62B | 39.31%6.22B | 47.90%4.47B | 37.92%3.02B | 4.54%2.19B | 223.15%2.09B |
Net profit before non-cash adjustment | -8.56%9.07B | 30.45%9.92B | 19.59%7.61B | -10.85%6.36B | 34.58%7.13B | 17.85%5.3B | 50.18%4.5B | 35.58%3B | --2.21B | ---- |
Total adjustment of non-cash items | -44.47%487M | -11.32%877M | 364.32%989M | -60.48%213M | -47.05%539M | 211.31%1.02B | 95.81%327M | -25.11%167M | -86.90%223M | 164.70%1.7B |
-Depreciation and amortization | 90.82%748M | -7.98%392M | -9.17%426M | -0.85%469M | 23.18%473M | -9.86%384M | 48.95%426M | 27.68%286M | -87.67%224M | 112.51%1.82B |
-Reversal of impairment losses recognized in profit and loss | ---- | ---- | ---- | ---- | ---- | ---- | --48M | ---- | ---- | ---- |
-Share of associates | 12.50%-56M | -146.15%-64M | 84.05%-26M | -181.50%-163M | -67.74%200M | 1,292.31%620M | 67.50%-52M | -245.45%-160M | 339.13%110M | 84.46%-46M |
-Disposal profit | -497.10%-412M | -245.00%-69M | 91.67%-20M | -220.00%-240M | -3,850.00%-75M | -92.00%2M | 38.89%25M | 139.13%18M | -4,500.00%-46M | 98.86%-1M |
-Other non-cash items | -66.50%207M | 1.48%618M | 314.29%609M | 349.15%147M | -591.67%-59M | 110.00%12M | -621.74%-120M | 135.38%23M | 4.41%-65M | -174.73%-68M |
Changes in working capital | 75.85%-206M | -42.64%-853M | -4,086.67%-598M | 127.27%15M | 44.44%-55M | 72.50%-99M | -151.75%-360M | 41.15%-143M | -161.99%-243M | 7,740.00%392M |
-Change in receivables | 107.41%130M | -34.20%-1.75B | -1,344.76%-1.31B | 118.45%105M | 3.40%-569M | -8.67%-589M | -179.38%-542M | 42.43%-194M | 6.65%-337M | -1,303.33%-361M |
-Change in inventory | ---- | ---- | ---- | ---- | --11M | ---- | -500.00%-12M | 0.00%3M | 175.00%3M | -33.33%-4M |
-Change in payables | -165.81%-204M | -18.85%310M | 506.38%382M | -139.83%-94M | -31.20%236M | 29.43%343M | 2,309.09%265M | 123.40%11M | -107.54%-47M | 769.89%623M |
-Change in accrued expense | -110.00%-33M | 9.63%330M | 4,400.00%301M | -103.68%-7M | 9,400.00%190M | 150.00%2M | -107.02%-4M | -30.49%57M | -28.07%82M | 5,600.00%114M |
-Provision for loans, leases and other losses | -137.93%-99M | 903.85%261M | 136.36%26M | -85.71%11M | -46.90%77M | 316.42%145M | -235.00%-67M | -135.71%-20M | 116.52%56M | -591.30%-339M |
-Changes in other current liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --359M |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | 0.00%-7M | 0.00%-7M | 0.00%-7M | 46.15%-7M | -116.67%-13M | 40.00%-6M | -25.00%-10M | 0.00%-8M | 0.00%-8M | 0.00%-8M |
Interest received (cash flow from operating activities) | 66.67%5M | -93.33%3M | 40.63%45M | 190.91%32M | -35.29%11M | 325.00%17M | 100.00%4M | 0.00%2M | 0.00%2M | 0.00%2M |
Tax refund paid | -34.08%-4.19B | -91.48%-3.13B | 36.72%-1.63B | -16.86%-2.58B | -25.61%-2.21B | -214.31%-1.76B | 34.54%-559M | -1.07%-854M | -792.62%-845M | 192.42%122M |
Other operating cash inflow (outflow) | 104.76%1M | 40.00%-21M | 36.36%-35M | -5,400.00%-55M | -1M | 0 | 0.00%1M | 0.00%1M | 200.00%1M | 0.00%-1M |
Operating cash flow | -24.03%5.16B | 6.72%6.8B | 60.04%6.37B | -26.42%3.98B | 20.88%5.41B | 14.69%4.47B | 80.60%3.9B | 61.31%2.16B | -39.38%1.34B | 333.99%2.21B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | 245.63%150M | -98.08%-103M | 65.33%-52M | 33.63%-150M | 5.83%-226M | -110.53%-240M | 66.27%-114M | -35.20%-338M | -212.50%-250M | -135.29%-80M |
Net intangibles purchase and sale | -1.10%-183M | -42.52%-181M | 1.55%-127M | 37.98%-129M | -258.62%-208M | 26.58%-58M | 51.83%-79M | -45.13%-164M | -54.79%-113M | 66.36%-73M |
Net business purchase and sale | -846.78%-7.93B | -1,962.22%-838M | 119.31%45M | -276.52%-233M | 133.42%132M | -863.41%-395M | 74.38%-41M | ---160M | ---- | ---- |
Net investment product transactions | 712.72%1.41B | 765.00%173M | -95.38%20M | 304.67%433M | 104.96%107M | ---2.16B | --0 | -282.09%-122M | --67M | --0 |
Advance cash and loans provided to other parties | ---- | ---- | ---- | ---- | ---- | ---29M | --0 | ---- | ---- | ---- |
Repayment of advance payments to other parties and cash income from loans | ---- | ---- | ---- | ---- | --33M | ---- | ---- | ---- | ---- | ---- |
Net changes in other investments | 2,266.67%195M | -160.00%-9M | 250.00%15M | -105.88%-10M | 1,445.45%170M | -76.60%11M | -4.08%47M | --49M | ---- | 0.00%-1M |
Investing cash flow | -564.51%-6.37B | -867.68%-958M | -11.24%-99M | -1,212.50%-89M | 100.28%8M | -1,434.76%-2.87B | 74.56%-187M | -148.31%-735M | -92.21%-296M | -252.48%-154M |
Financing cash flow | ||||||||||
Net issuance payments of debt | -1,213.04%-604M | 42.50%-46M | ---80M | ---- | 115.36%118M | -1,213.04%-768M | 7,000.00%69M | ---1M | ---- | ---- |
Net common stock issuance | -123.37%-2.03B | -63.72%-907M | 44.32%-554M | -17.47%-995M | -23.65%-847M | -37.00%-685M | -400.00%-500M | ---100M | ---- | ---- |
Cash dividends paid | -37.67%-2.3B | -6.11%-1.67B | -6.44%-1.57B | -6.88%-1.48B | -30.78%-1.38B | -20.69%-1.06B | -14.08%-875M | 16.72%-767M | -72.15%-921M | ---535M |
Net other fund-raising expenses | -1,350.00%-29M | -105.41%-2M | 3,800.00%37M | -102.70%-1M | 3,600.00%37M | --1M | ---- | ---- | ---- | ---- |
Financing cash flow | -88.94%-4.95B | -20.94%-2.62B | 12.30%-2.17B | -19.25%-2.47B | 17.34%-2.07B | -92.04%-2.51B | -50.46%-1.31B | 5.75%-868M | -72.15%-921M | ---535M |
Net cash flow | ||||||||||
Beginning cash position | 18.47%20.63B | 30.81%17.41B | 12.68%13.31B | 39.49%11.81B | -9.65%8.47B | 34.58%9.37B | 8.69%6.96B | 1.94%6.41B | 31.93%6.28B | 14.72%4.76B |
Current changes in cash | -291.45%-6.16B | -21.58%3.22B | 189.21%4.1B | -57.58%1.42B | 469.80%3.34B | -137.54%-904M | 332.32%2.41B | 356.56%557M | -91.97%122M | 149.18%1.52B |
Effect of exchange rate changes | --0 | --0 | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash adjustments other than cash changes | ---1M | ---- | ---- | 7,900.00%80M | --1M | ---- | ---- | ---- | ---- | 0.00%1M |
End cash Position | -29.86%14.47B | 18.47%20.63B | 30.81%17.41B | 12.68%13.31B | 39.49%11.81B | -9.65%8.47B | 34.58%9.37B | 8.69%6.96B | 1.94%6.41B | 31.93%6.28B |
Free cash flow | -25.31%4.86B | 5.22%6.51B | 67.27%6.19B | -25.61%3.7B | 19.11%4.97B | 12.62%4.18B | 123.64%3.71B | 69.88%1.66B | -52.53%976M | 696.90%2.06B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |